- 4009 Hackney Springs Ln, Sachse, TX 75048
Pathology billing runs on a completely different logic than clinical chemistry or hospital billing. Specimen-based units, professional/technical component splits, subspecialty stain protocols, and molecular reflex pathways aren’t something a generalist billing company was ever built to handle. And the revenue loss compounds quietly, case after case, until a full coding audit finally reveals how much was left on the table.
Specimen Miscounting
Professional/Technical Component Split Errors
Prostate Biopsy Unit Errors
Missed Special Stain and IHC Capture
Molecular Pathology Coding Gaps
TransLabs’ specialized RCM services are built exclusively for labs, addressing the unique challenges that generalist billers miss. We provide end-to-end revenue cycle solutions designed specifically to turn laboratory complexity into profitability.
Complete payer enrollment, CLIA certification management, and network participation setup across all insurance carriers. TransLabs manages every credentialing detail so that your laboratory gets paid in-network from day one without any administrative delays.
Real-time insurance verification, benefits investigation, and prior auth completed before specimen processing begins. Confirming coverage upfront eliminates preventable denials and protects your lab from unexpected reimbursement failures.
Patient registration, appointment coordination, insurance verification, and customer service excellence managed by experienced laboratory billing professionals. A well-run front office reduces downstream billing errors and creates a better experience.
TransLabs provides expert RCM services to clinical laboratories in all 50 states, delivering the same exceptional results whether you’re a community hospital lab or a large reference facility. We bring specialized lab billing expertise to facilities nationwide, combining remote efficiency with hands-on partnership.
Each Medicare Administrative Contractor maintains its own LCD policies specifying which ICD-10 diagnosis codes support coverage for pathology services, and molecular tests processed under the MolDX program additionally require a registered Z-Code identifier before a claim can even be submitted correctly. TransLabs maintains live LCD and Z-Code databases for every MAC and validates every pathology and molecular claim before it goes out the door.
When a pathologist interprets a specimen processed on equipment they don't own, whether at a hospital or an independent reference lab, the claim must correctly split between the professional component (modifier 26) and technical component (modifier TC), or be billed globally when the same entity owns both. Getting this split wrong is one of the most common and costly errors in pathology billing, and TransLabs builds ownership verification into every claim before submission.
When a Medicare beneficiary requests additional testing that may not meet medical necessity criteria under the applicable LCD, such as an add-on molecular panel, a valid ABN must be issued before the test is performed. Retroactive ABNs are not valid, and billing without one when coverage is uncertain exposes the practice to recoupment. TransLabs builds ABN workflows directly into requisition intake so documentation is always in place.
Pathology reimbursement has faced steady downward pressure, including cuts to the Medicare Physician Fee Schedule conversion factor and an efficiency adjustment applied to many non-time-based pathology codes. TransLabs monitors every annual rate change, updates billing tables immediately, and flags when a commercial payer is reimbursing below the current CLFS or PFS rate.
Independent pathology laboratories meeting the applicable laboratory definition under the Protecting Access to Medicare Act carry mandatory private payer data reporting obligations during designated collection periods, with civil monetary penalties for non-compliance. TransLabs tracks your practice's PAMA obligations year-round and ensures reporting is accurate and on time.
The Office of Inspector General's annual Work Plan regularly features pathology billing, with molecular and genetic testing, tumor markers, and high-volume specimen counting drawing particular scrutiny in recent cycles. TransLabs builds compliance protocols specifically around current OIG focus areas so audit exposure gets addressed before it becomes a problem.
Most billing companies treat physicians, hospitals, and pathology practices the same. They’re not. Pathology billing has its own CPT codes, component-split logic, subspecialty rules, and audit exposure. TransLabs was built exclusively for pathology and lab billing; every coder, account manager, and appeal writer works only in pathology, no exceptions.
Dedicated billing specialist assigned to your practice
Complimentary 12-month claims audit across Medicare, Medicaid, and commercial payers
Uncover your top 3 revenue leaks (specimen miscounts, TC/26 errors, molecular coding gaps)
Custom strategy tailored to your subspecialty mix and LIS/AP software
Live in 24 hours with no contracts and no upfront fees
Pay only a percentage of what we collect for you
Pathology billing covers tissue and cellular diagnosis, often called histopathology when referring specifically to tissue examination, using CPT codes 88000-88399 for surgical pathology, cytology, and related services, plus molecular pathology codes in the 81000 series. It also requires correctly splitting the professional interpretation from the technical processing work, something clinical chemistry and hematology billing rarely involves in the same way.
